drugset / Trial / NCT03120299

The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)

NCT03120299

Phase 4 Completed 309 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to conduct a multicenter randomized, double-blind, placebo-controlled clinical trial, evaluating the effects and change of lipid metabolism, especially of triglyceride after omega-3 administration in type 2 diabetes patients with hypertriglyceride.

Timeline

Start
2017-05-01
Primary completion
2021-03-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovaza Other / unclassified 2 g Oral